Carcinoid syndrome

1Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Gastroenteropancreatic neuroendocrine neoplasms (GEP NEN) oversecreting hormones and/or biogenic amines are the causes of specific hormonal syndromes, such as carcinoid syndrome in serotonin-secreting tumors, Zollinger-Ellison syndrome in gastrinoma, hypoglycemic syndrome in insulinoma, Verner-Morrison syndrome (VIPoma), and others. Management of hormonal symptoms, which are often life-threatening, requires interdisciplinary approach and implementation of multiple therapeutic methods. This chapter presents the management guidelines, using surgical and endoscopic methods, and pharmacotherapy, including biotherapy, isotope treatments, chemotherapy, and targeted molecular therapy applied in the symptomatic treatment of GEP-NEN clinical syndromes.

Cite

CITATION STYLE

APA

Kilickap, S., & Yalcin, S. (2015). Carcinoid syndrome. In Neuroendocrine Tumours: Diagnosis and Management (pp. 513–522). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-45215-8_29

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free